The decline of amniocentesis and the increase of chorionic villus sampling in modern perinatal medicine

被引:9
作者
Monni, Giovanni [1 ]
Corda, Valentina [2 ]
Iuculano, Ambra [2 ]
Afshar, Yalda [3 ]
机构
[1] Microcitem Pediat Hosp Antonio Cao, Dept Obstet & Gynecol, Prenatal & Preimplantat Genet Diag Fetal Therapy, Via Edward Lenner SNC, I-09121 Sardinia, Italy
[2] Microcitem Pediat Hosp Antonio Cao, Dept Obstet & Gynecol, Prenatal & Preimplantat Genet Diag, Fetal Therapy, Cagliari, Italy
[3] Univ Calif Los Angeles, Dept Obstet & Gynecol, Div Maternal Fetal Med, Los Angeles, CA 90024 USA
关键词
amniocentesis; chorionic villous sampling; fetal cell-free DNA; prenatal screening; training in invasive prenatal procedures; FETAL NUCHAL-TRANSLUCENCY; PRENATAL-DIAGNOSIS; SCREENING-PROGRAM; MATERNAL AGE; RISK; ULTRASOUND; WOMEN; ABNORMALITIES; THALASSEMIA; TRISOMY-21;
D O I
10.1515/jpm-2020-0035
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The aims of this study were to determine the rate of change by type of diagnosis by transabdominal chorionic villus sampling (TA-CVS) vs. amniocentesis for aneuploidy and to describe a successful and intensive international training program for TA-CVS in ongoing pregnancies. Methods: We conducted a retrospective cohort study of all deliveries from 2010 to 2018 in Sardinia. All invasive diagnostic procedures are conducted at a single regional perinatal referral center. Descriptive statistics were used to compare data across groups, and inter-correlations between variables were investigated by Pearson's -correlation coefficient. We subsequently describe the international trainee experiences in TA- CVS over a 35-year period. Results: A total of 101,025 deliveries occurred over 9 years. The number of deliveries (13,413-9143, P < 0.0001) and total invasive diagnostic procedures (1506-858 per year, P = 0.019) declined over this period. The percentage of deliveries undergoing invasive diagnostic procedures remained steady (mean: 12.2%). In 2010, TA-CVS made up 32.3% of all invasive diagnostic procedures, while amniocentesis made up 67.7%. By 2018, TA-CVS made up 61.3% of the invasive diagnostic procedures, and amniocentesis, only 38.7%. The rate of TA-CVS increased over 9 years, while the rate of amniocentesis declined. A total of 236 trainees from 39 different countries and 5 different continents rotated through this site. The average length of stay was 2.4 weeks. Conclusion: We demonstrate an increasing prevalence of TA-CVS vs. amniocentesis in the current era of prenatal testing and underscore the importance of continuing to train specialists skilled in TA-CVS. Our global operative experience is feasible and sustainable and will have a lasting impact on physicians conducting invasive fetal procedures.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 42 条
[1]   Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis [J].
Akolekar, R. ;
Beta, J. ;
Picciarelli, G. ;
Ogilvie, C. ;
D'Antonio, F. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (01) :16-26
[2]   Women who choose cell-free DNA testing should not be denied first-trimester anatomy scan [J].
Alfirevic, Z. ;
Bilardo, C. M. ;
Salomon, L. J. ;
Tabor, A. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (08) :1159-1161
[3]   The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion [J].
Penzias A. ;
Bendikson K. ;
Butts S. ;
Coutifaris C. ;
Falcone T. ;
Fossum G. ;
Gitlin S. ;
Gracia C. ;
Hansen K. ;
La Barbera A. ;
Mersereau J. ;
Odem R. ;
Paulson R. ;
Pfeifer S. ;
Pisarska M. ;
Rebar R. ;
Reindollar R. ;
Rosen M. ;
Sandlow J. ;
Vernon M. ;
Widra E. .
FERTILITY AND STERILITY, 2018, 109 (03) :429-436
[4]  
[Anonymous], GENETIC DISORDERS FE
[5]  
[Anonymous], J MATERN FETAL NEONA
[6]   Detection of Fetal Structural Anomalies in a Basic First-Trimester Screening Program for Aneuploidy [J].
Bromley, Bryann ;
Shipp, Thomas D. ;
Lyons, Jennifer ;
Navathe, Reshama S. ;
Groszmann, Yvette ;
Benacerraf, Beryl R. .
JOURNAL OF ULTRASOUND IN MEDICINE, 2014, 33 (10) :1737-1745
[7]   Screening for thalassemia - A model of success [J].
Cao, A ;
Rosatelli, MC ;
Monni, G ;
Galanello, R .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2002, 29 (02) :305-+
[8]   CHORIONIC VILLUS SAMPLING AND ACCEPTANCE RATE OF PRENATAL-DIAGNOSIS [J].
CAO, A ;
COSSU, P ;
MONNI, G ;
ROSATELLI, MC .
PRENATAL DIAGNOSIS, 1987, 7 (07) :531-533
[9]   Prenatal Diagnosis Screening and Diagnostic Tools [J].
Carlson, Laura M. ;
Vora, Neeta L. .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2017, 44 (02) :245-+
[10]   Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues [J].
Gekas, Jean ;
Langlois, Sylvie ;
Ravitsky, Vardit ;
Audibert, Francois ;
van den Berg, David Gradus ;
Haidar, Hazar ;
Rousseau, Francois .
APPLICATION OF CLINICAL GENETICS, 2016, 9 :15-26